Compounded GLP-1 formulations, which may be used for microdosing, carry additional risks, including uncertain drug quality and imprecise dosing that may be especially dangerous for people who also take insulin
Common manifestations include ovarian cysts, irregular menstrual periods, impaired fertility, obesity, hirsutism, acne and increased risk of cardiovascular disease
Curr Ther Res 1982;31:1042-1048
ERK1/2 Inhibition Overcomes Resistance to Venetoclax in AML By Inhibiting Drp1 Dependent Mitochondrial Fission - Oral Presentation
Ideally, well start you out with a small dosage of GLP-1, then gradually build your dosage up over time
Whichever semaglutide program you choose, check in with a licensed medical professional before starting